期刊文献+

血浆结合珠蛋白浓度与早发冠心病的关系研究

Relationship between concentration of plasma haptoglobin and premature coronary heart disease
下载PDF
导出
摘要 目的检测早发冠心病(PCHD)患者血浆结合珠蛋白(Hp)水平,观察不同类型早发冠心病患者血浆珠蛋白水平。方法纳入2010年5月~2011年1月PCHD患者72例,同期纳入健康体检者74例作为对照组。将PCHD组依诊断进一步分为稳定性心绞痛组(SA,n=15)、不稳定性心绞痛组(UA,n=36)和急性心肌梗死组(AMI,n=21);检测并比较各组Hp浓度的差异。结果 PCHD组Hp浓度高于对照组,差异有统计学意义[(1.785±0.525)ng/mLvs.(0.869±0.172)ng/mL,P<0.05];SA组、UA组和AMI组Hp浓度分别为(1.699±0.723)ng/mL、(1.685±0.453)ng/mL和(1.946±0.584)ng/mL,组间比较无明显差异(P=0.281)。结论 PCHD患者血浆Hp浓度明显升高,且与类型无关。 Objective To detect the level of plasma haptoglobin ( Hp ) in the patients with early coronary heart disease ( PCHD ) , and investigate the relationship between Hp and early PCHD or types of early PCHD. Methods The patients with early PCHD ( n =72 ) were selected as PCHD group from May, 2010 to Jan. 2011, and other health people ( n =74 ) were selected as control group at the same period. PCHD group was further divided into stable angina group ( SA group, n =15 ) , unstable angina group ( UA group, n =36 ) and acute myocardial infarction ( AMI group, n =21 ) . The difference in Hp concentration were detected and compared among all groups. Results Hp concentration was higher in PCHD group than that in control group [ ( 1.785 ± 0.525 ) ng/ mL vs . ( 0.869 ± 0.172 ) ng/mL, P 0.05], and was, respectively, (1.699 ± 0.723) ng/mL, (1.685 ± 0.453) ng/mL and (1.946 ± 0.584) ng/mL in SA group, UA group and AMI group, and there was no significant difference in the comparison among groups ( P =0.281 ) . Conclusion Hp concentration increases significantly in the patients with early PCHD, which is not related to types of PCHD.
出处 《中国循证心血管医学杂志》 2012年第6期518-520,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
基金 青岛市科研基金(2008014)
关键词 冠心病 结合珠蛋白 相关性 coronary heart disease Haptoglobin Delalionship
  • 相关文献

参考文献18

  • 1方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 2Langlois MR,Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans[J].Clinical Chemistry,1996,(10):1589-1600.
  • 3Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention[J].Circulation,2003,(03):363-369.
  • 4AziziF,Rahmani M,Raiszadeh F. Association of lipids,lipoproteins,apolipoproteins and paraoxonase enzyme activity with earlyonset coronary artery disease[J].Coronary Artery Disease,2002,(01):9-16.doi:10.1097/00019501-200202000-00002.
  • 5Pearson TA,Mensah GA,Alexander RW. Markers of inflammation and cardiovascular disease-application to clinical and public health practice[J].Circulation,2003,(05):499-511.
  • 6王雁,胡申江.冠状动脉病变与胰岛素抵抗、高敏C反应蛋白的关系[J].临床心血管病杂志,2008,24(10):745-747. 被引量:16
  • 7胡大一;马长生.心脏病学实践[M]北京:人民卫生出版社,200814-17.
  • 8Roos R. Atherosclerosis-an inflammatory disease[J].New England Journal of Medicine,1999,(02):115-126.
  • 9Asleh R,Marsh S,Shilkrut M. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease[J].Circulation Research,2003,(11):1193-1200.
  • 10Nielsen MJ,Petersen SV,Jacobsen C. Aunique loop extension in the serinwe protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex[J].Journal of Biological Chemistry,2007,(02):1072-1079.

二级参考文献9

共引文献3084

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部